EGFR and idiopathic pulmonary fibrosis: Notable examples included the predicted activation of the EREG-EGFR ligand-receptor in the Myeloid-enriched IPF subset and the predicted activation of CTGF signaling and the high level expression of CXCL13 in the Ciliated epithelium-enriched IPF subset (Fig 7B–7E).